Abeona Therapeutics Inc. (ABEO) Financials
ABEO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 198.5 million | 53.6 million |
| Dec. 31, 2025 | 219.6 million | 60.4 million |
| Sept. 30, 2025 | 231.1 million | 59.9 million |
| June 30, 2025 | 246.2 million | 82.7 million |
ABEO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -20.7 million | 3.0 million |
| Dec. 31, 2025 | -19.1 million | -142000 |
| Sept. 30, 2025 | -23.7 million | 2.7 million |
| June 30, 2025 | -21.7 million | 2.8 million |
ABEO Net Income
No data available :(
ABEO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 168.3 million | 8.6 million | 5.1 million |
| Dec. 31, 2025 | 191.4 million | 7.8 million | 4.1 million |
| Sept. 30, 2025 | 207.5 million | 10.9 million | 4.3 million |
| June 30, 2025 | 225.5 million | 14.0 million | 4.5 million |
ABEO Shares Outstanding
ABEO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 935000 | 9.6 million | 18.6 million | - |
| Dec. 31, 2025 | 1.2 million | 6.7 million | 18.8 million | - |
| Sept. 30, 2025 | 2.5 million | 4.2 million | 19.3 million | - |
| June 30, 2025 | 2.9 million | 5.9 million | 17.1 million | - |
ABEO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 8.7 million | 3.6 million |
| Dec. 31, 2025 | 5.4 million | 2.8 million |
| Sept. 30, 2025 | - | 488000 |
| June 30, 2025 | 400000 | 100000 |
ABEO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ABEO
Price: $6.05
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.95 USD
P/E Ratio: 5.54
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 254600
Ebitda: -5.2 millionMarket Capitalization: 364.8 million